USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$204.51M
Market Cap
-
P/E Ratio
-2.06
EPS
$18.55
52 Week High
$4.29
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $43M |
Total Revenue | $51M |
Cost Of Revenue | $8.3M |
Costof Goods And Services Sold | $8.3M |
Operating Income | -$59M |
Selling General And Administrative | $91M |
Research And Development | $11M |
Operating Expenses | $102M |
Investment Income Net | - |
Net Interest Income | -$4.4M |
Interest Income | - |
Interest Expense | $4.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $619K |
Income Before Tax | -$60M |
Income Tax Expense | $55K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$60M |
Comprehensive Income Net Of Tax | - |
Ebit | -$56M |
Ebitda | -$55M |
Net Income | -$60M |
Field | Value (USD) |
---|---|
Total Assets | $133M |
Total Current Assets | $130M |
Cash And Cash Equivalents At Carrying Value | $106M |
Cash And Short Term Investments | $106M |
Inventory | $12M |
Current Net Receivables | $9.3M |
Total Non Current Assets | $3.6M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.5M |
Other Non Current Assets | - |
Total Liabilities | $62M |
Total Current Liabilities | $11M |
Current Accounts Payable | $2.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $564K |
Total Non Current Liabilities | $52M |
Capital Lease Obligations | $1.2M |
Long Term Debt | $49M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $50M |
Other Current Liabilities | $7.5M |
Other Non Current Liabilities | $1.4M |
Total Shareholder Equity | $71M |
Treasury Stock | - |
Retained Earnings | -$537M |
Common Stock | $253K |
Common Stock Shares Outstanding | $23M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$39M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $619K |
Capital Expenditures | $1.4M |
Change In Receivables | - |
Change In Inventory | -$1.1M |
Profit Loss | - |
Cashflow From Investment | -$1.4M |
Cashflow From Financing | $56M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$60M |
Field | Value (USD) |
---|---|
Gross Profit | $43M |
Total Revenue | $51M |
Cost Of Revenue | $8.3M |
Costof Goods And Services Sold | $8.3M |
Operating Income | -$59M |
Selling General And Administrative | $91M |
Research And Development | $11M |
Operating Expenses | $102M |
Investment Income Net | - |
Net Interest Income | -$4.4M |
Interest Income | - |
Interest Expense | $4.4M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $619K |
Income Before Tax | -$60M |
Income Tax Expense | $55K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$60M |
Comprehensive Income Net Of Tax | - |
Ebit | -$56M |
Ebitda | -$55M |
Net Income | -$60M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.